prikaz prve stranice dokumenta International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
British Journal of Haematology, (2022); https://doi.org/10.1111/bjh.18072
(EORTC Quality of Life Group) Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M.; Kyriakou, Charalampia; Xochelli, Aliki; Levedahl, Kerstin; Petranović, Duška; Borges, Fabio Cardoso; Bredart, Anne; Shamieh, Omar; Gziskevicius, Laimonas; Lehmann, Jens; Scholz, Christian W.; Caocci, Giovanni; Molica, Stefano; Stamatopoulos, Kostas; Panteliadou, Alkistis‐Kyra; Papaioannou, Maria; Alrjoob, Waleed; Baliakas, Panagiotis; Rosenquist, Richard; Malak, Sandra; Miranda, Ana; Cocks, Kim; Poll‐Franse, Lonneke Više autora...

Citirajte ovaj rad

Oerlemans, S., Efficace, F., Kieffer, J. M., Kyriakou, C., Xochelli, A., Levedahl, K. ... Poll‐Franse, L. (2022). International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia. British Journal of Haematology. doi: 10.1111/bjh.18072

Oerlemans, Simone, et al. "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia." British Journal of Haematology, 2022. https://doi.org/10.1111/bjh.18072

Oerlemans, Simone, Fabio Efficace, Jacobien M. Kieffer, Charalampia Kyriakou, Aliki Xochelli, Kerstin Levedahl, Duška Petranović, et al. "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia." British Journal of Haematology (2022). https://doi.org/10.1111/bjh.18072

Oerlemans, S., et al. (2022) 'International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia', British Journal of Haematology. doi: 10.1111/bjh.18072

Oerlemans S, Efficace F, Kieffer JM, Kyriakou C, Xochelli A, Levedahl K, i sur.. International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia. British Journal of Haematology [Internet]. 07.03.2022. [pristupljeno 18.11.2024.]. doi: 10.1111/bjh.18072

S. Oerlemans, et al., "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia", British Journal of Haematology, Ožujak 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:932551. [Citirano: 18.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:932551
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
AutorSimone Oerlemans
AutorFabio Efficace
AutorJacobien M. Kieffer
AutorCharalampia Kyriakou
AutorAliki Xochelli
AutorKerstin Levedahl
AutorDuška Petranović
AutorFabio Cardoso Borges
AutorAnne Bredart
AutorOmar Shamieh
AutorLaimonas Gziskevicius
AutorJens Lehmann
AutorChristian W. Scholz
AutorGiovanni Caocci
AutorStefano Molica
AutorKostas Stamatopoulos
AutorAlkistis‐Kyra Panteliadou
AutorMaria Papaioannou
AutorWaleed Alrjoob
AutorPanagiotis Baliakas
AutorRichard Rosenquist
AutorSandra Malak
AutorAna Miranda
AutorKim Cocks
AutorLonneke Poll‐Franse
KolaboracijaEORTC Quality of Life Group
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Selecting the most appropriate chronic lymphocytic leukaemia (CLL) treatment is challenging. Patient-reported health-related quality of life (HRQoL) is therefore a critical aspect to consider. This international study by the European Organization for Research and Treatment of Cancer (EORTC) tested the psychometric properties of a newly developed measure for CLL patients: the EORTC QLQ-CLL17 to supplement the core questionnaire (EORTC QLQ-C30). Patients with CLL (n = 341) from 12 countries completed the QLQ-C30, QLQ-CLL17 and a debriefing questionnaire. Sociodemographic and clinical data were recorded from medical records. A high percentage (30%-66%) reported symptoms and/or worries (e.g. aches/pains in muscles, lack of energy and worry/fears about health). Confirmatory factor analysis showed an acceptable to good fit of the 17 items on the three scales (i.e. symptom burden, physical condition/fatigue and worries/fears about health and functioning). Completion took on average 8 min. Test-retest and convergent validity was demonstrated. The QLQ-CLL17 differentiated between patients with an Eastern Cooperative Oncology group (ECOG) performance of 0 versus 1-3 (p's < 0.01 and clinically relevant). The newly developed EORTC QLQ-CLL17 will increase sensitivity of HRQoL assessment in patients with CLL. Implementation of this questionnaire both in clinical research and practice will help to generate unique clinically relevant data to better inform CLL treatment decision-making.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objavePrihvaćen za objavljivanje
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBritish Journal of Haematology
p-ISSN0007-1048
e-ISSN1365-2141
DOIhttps://doi.org/10.1111/bjh.18072
URN:NBNurn:nbn:hr:184:932551
Datum objave publikacije2022-03-07
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1111/bjh.18072
Vrsta resursaTekst
Prava pristupaZatvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-03-10 21:41:01